共 66 条
[1]
Mannino DM(1998)Surveillance for Asthma—United States 1960–1995 MMWR CDC Surveill Summ 47 1-27
[2]
Homa DM(1997)Inhaled steroids and the risk of hospitalization for asthma JAMA 277 887-91
[3]
Pertowski CA(1998)First treatment with inhaled corticosteroids and the prevention of admissions to hospitals for asthma Thorax 53 1025-9
[4]
Donahue JG(1996)The costs of asthma Eur Respir J 9 636-42
[5]
Weiss ST(1998)Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a Medicaid population of asthmatic patients Clin Ther 20 567-80
[6]
Livingston JM(1987)Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 225-44
[7]
Goetsch MA(1998)Utility of peak expiratory flow monitoring Chest 114 861-76
[8]
Greineder DK(1994)Measures of life quality, role performance and functional status in asthma research Am J Respir Crit Care Med 149 S31-S9
[9]
Platt R(2001)A pharmaceutical care program for patients with reactive airway disease Am J Health Sys Pharm 58 791-6
[10]
Blaiss L(2002)The effectiveness of pharmaceutical care for patients with reactive airways disease: a randomized, controlled trial in community pharmacies JAMA 288 1594-602